Clinical Trial Update: Study to Evaluate the Efficacy and Safety of JP-1366 in the Prevention of NSAIDs-Induced Peptic Ulcers [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating JP-1366 to prevent NSAIDs-induced peptic ulcers is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer

Drugs mentioned

• JP-1366

Snippet

Sponsor: Onconic Therapeutics Inc. | Conditions: Peptic Ulcer | Phase 3 | Status: RECRUITING